( nce of patent expiration creating its ...)The deconstruction of Big Pharma

nce of patent expiration, creating its own new generic divisions, and accelerating an ethical-to-OTC- switch.

They will have to as Teva, the world's largest generic company, surpassed Pfizer in the first six months of 2006, for the first time, in total prescriptions. In an article in the Economist, it is estimated that by 2010, six to eight Indi......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 02/12/07


Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
4. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
5. Deltanoid Pharmaceuticals begins phase II osteoporosis study
6. First half of 2006 roundup: Big Pharma trumps biotech
7. Big Pharmas continued hunger and search for new products
8. Leading global Big Pharma companies of 2005
9. Theres more than a bit of mystery, but attracting Big Pharma is good for the state
10. Biotech flourishes in 2005 while Big Pharma is on the decline
11. Big Pharma already has a generic strategy, but needs new direction